Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:1524-1532
Published online before print March 9, 2009, doi: 10.1161/CIRCULATIONAHA.108.823997
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
119/11/1524    most recent
CIRCULATIONAHA.108.823997v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pang, J.
Right arrow Articles by Berk, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pang, J.
Right arrow Articles by Berk, B. C.
Related Collections
Right arrow Angiogenesis
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrow Other Research
Right arrowRelated Article

(Circulation. 2009;119:1524-1532.)
© 2009 American Heart Association, Inc.


Vascular Medicine

G-Protein–Coupled Receptor Kinase Interacting Protein-1 Is Required for Pulmonary Vascular Development

Jinjiang Pang, MD, PhD; Ryan Hoefen, MD, PhD; Gloria S. Pryhuber, MD; Jing Wang, MD, PhD; Guoyong Yin, MD, PhD; R. James White, MD, PhD; Xiangbin Xu, PhD; Michael R. O'Dell, BS; Amy Mohan, BS; Heidi Michaloski, BS; Michael P. Massett, PhD; Chen Yan, PhD; Bradford C. Berk, MD, PhD

From the Aab Cardiovascular Research Institute and the Department of Medicine (J.P., R.H., J.W., G.Y., R.J.W., M.R.O., A.M., H.M., M.P.M., C.Y., B.C.B.); Department of Pediatrics (G.S.P.); and Department of Microbiology and Immunology (X.X.), University of Rochester School of Medicine and Dentistry, Rochester, NY.

Correspondence to Bradford C. Berk, MD, PhD, University of Rochester Medical Center, Box 706, 601 Elmwood Ave, Rochester, NY 14642. E-mail Bradford_Berk{at}URMC.rochester.edu

Received September 27, 2008; accepted January 15, 2009.

Background— The G-protein–coupled receptor kinase interacting protein-1 (GIT1) is a multidomain scaffold protein that participates in many cellular functions including receptor internalization, focal adhesion remodeling, and signaling by both G-protein–coupled receptors and tyrosine kinase receptors. However, there have been no in vivo studies of GIT1 function to date.

Methods and Results— To determine essential functions of GIT1 in vivo, we generated a traditional GIT1 knockout mouse. GIT1 knockout mice exhibited {approx}60% perinatal mortality. Pathological examination showed that the major abnormality in GIT1 knockout mice was impaired lung development characterized by markedly reduced numbers of pulmonary blood vessels and increased alveolar spaces. Given that vascular endothelial growth factor (VEGF) is essential for pulmonary vascular development, we investigated the role of GIT1 in VEGF signaling in the lung and cultured endothelial cells. Because activation of phospholipase-C{gamma} (PLC{gamma}) and extracellular signal-regulated kinases 1/2 (ERK1/2) by angiotensin II requires GIT1, we hypothesized that GIT1 mediates VEGF-dependent pulmonary angiogenesis by modulating PLC{gamma} and ERK1/2 activity in endothelial cells. In cultured endothelial cells, knockdown of GIT1 decreased VEGF-mediated phosphorylation of PLC{gamma} and ERK1/2. PLC{gamma} and ERK1/2 activity in lungs from GIT1 knockout mice was reduced postnatally.

Conclusions— Our data support a critical role for GIT1 in pulmonary vascular development by regulating VEGF-induced PLC{gamma} and ERK1/2 activation.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 1457-1458. [Extract] [Full Text]